IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 194 filers reported holding IMMUNOGEN INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,532,649 | +86.1% | 119,145 | -0.4% | 0.02% | +25.0% |
Q3 2023 | $1,898,449 | -13.9% | 119,625 | +2.4% | 0.01% | -7.7% |
Q2 2023 | $2,204,431 | +454.0% | 116,822 | +12.7% | 0.01% | +333.3% |
Q1 2023 | $397,916 | -21.0% | 103,624 | +2.0% | 0.00% | -25.0% |
Q4 2022 | $503,748 | +3.4% | 101,562 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $487,000 | +7.7% | 101,932 | +1.4% | 0.00% | +33.3% |
Q2 2022 | $452,000 | -11.0% | 100,491 | -5.8% | 0.00% | 0.0% |
Q1 2022 | $508,000 | -34.9% | 106,706 | +1.5% | 0.00% | -25.0% |
Q4 2021 | $780,000 | +27.0% | 105,116 | -2.9% | 0.00% | +33.3% |
Q3 2021 | $614,000 | -15.0% | 108,261 | -1.1% | 0.00% | +50.0% |
Q2 2021 | $722,000 | -20.3% | 109,485 | -2.1% | 0.00% | -33.3% |
Q1 2021 | $906,000 | +30.7% | 111,795 | +4.1% | 0.00% | 0.0% |
Q4 2020 | $693,000 | +87.3% | 107,387 | +4.5% | 0.00% | +50.0% |
Q3 2020 | $370,000 | -23.4% | 102,739 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $483,000 | +41.6% | 105,075 | +5.0% | 0.00% | 0.0% |
Q1 2020 | $341,000 | -26.5% | 100,026 | +10.1% | 0.00% | 0.0% |
Q4 2019 | $464,000 | +109.0% | 90,816 | -0.8% | 0.00% | +100.0% |
Q3 2019 | $222,000 | +11.0% | 91,581 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $200,000 | -19.4% | 92,218 | +0.7% | 0.00% | 0.0% |
Q1 2019 | $248,000 | -45.4% | 91,542 | -3.1% | 0.00% | -50.0% |
Q4 2018 | $454,000 | -49.7% | 94,509 | -0.8% | 0.00% | -33.3% |
Q3 2018 | $902,000 | +11.1% | 95,235 | +14.1% | 0.00% | 0.0% |
Q2 2018 | $812,000 | +20.8% | 83,488 | +30.8% | 0.00% | +50.0% |
Q1 2018 | $672,000 | +55.9% | 63,848 | -5.1% | 0.00% | +100.0% |
Q4 2017 | $431,000 | -0.2% | 67,280 | +19.2% | 0.00% | -50.0% |
Q3 2017 | $432,000 | +16.4% | 56,431 | +8.1% | 0.00% | +100.0% |
Q2 2017 | $371,000 | +84.6% | 52,212 | +0.7% | 0.00% | 0.0% |
Q1 2017 | $201,000 | +103.0% | 51,863 | +7.1% | 0.00% | – |
Q4 2016 | $99,000 | -99.9% | 48,445 | -0.3% | 0.00% | -100.0% |
Q3 2016 | $130,168,000 | -12.9% | 48,570 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $149,368,000 | -66.6% | 48,496 | -7.5% | 0.00% | -50.0% |
Q1 2016 | $447,000,000 | -40.7% | 52,418 | -5.6% | 0.00% | -33.3% |
Q4 2015 | $754,000,000 | +142433.1% | 55,549 | +0.8% | 0.00% | +50.0% |
Q3 2015 | $529,000 | -99.9% | 55,090 | -4.2% | 0.00% | -33.3% |
Q2 2015 | $827,281,000 | +50.3% | 57,530 | -6.4% | 0.00% | +50.0% |
Q1 2015 | $550,273,000 | +46.4% | 61,483 | -0.2% | 0.00% | 0.0% |
Q4 2014 | $375,961,000 | -44.6% | 61,633 | -3.8% | 0.00% | -33.3% |
Q3 2014 | $678,480,000 | -8.5% | 64,068 | +2.4% | 0.00% | 0.0% |
Q2 2014 | $741,336,000 | -22.3% | 62,560 | -2.1% | 0.00% | -25.0% |
Q1 2014 | $954,116,000 | +4.0% | 63,906 | +2.2% | 0.00% | 0.0% |
Q4 2013 | $917,257,000 | -16.7% | 62,526 | -3.4% | 0.00% | -33.3% |
Q3 2013 | $1,101,160,000 | +7.1% | 64,698 | +4.4% | 0.01% | 0.0% |
Q2 2013 | $1,027,983,000 | – | 61,964 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
Grace Capital | 49,500 | $228,000 | 0.20% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |